These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 37830514)
1. Impact of Mandated Case Review Policy on Opioid Discontinuation and Mortality Among High-Risk Long-Term Opioid Therapy Patients: The STORM Stepped-Wedge Cluster Randomized Controlled Trial. Li Y; Barr KD; Trafton JA; Oliva EM; Garrido MM; Frakt AB; Strombotne KL Subst Abus; 2023 Oct; 44(4):292-300. PubMed ID: 37830514 [TBL] [Abstract][Full Text] [Related]
2. Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial. Auty SG; Barr KD; Frakt AB; Garrido MM; Strombotne KL Addiction; 2023 May; 118(5):870-879. PubMed ID: 36495477 [TBL] [Abstract][Full Text] [Related]
3. Effect of a Predictive Analytics-Targeted Program in Patients on Opioids: a Stepped-Wedge Cluster Randomized Controlled Trial. Strombotne KL; Legler A; Minegishi T; Trafton JA; Oliva EM; Lewis ET; Sohoni P; Garrido MM; Pizer SD; Frakt AB J Gen Intern Med; 2023 Feb; 38(2):375-381. PubMed ID: 35501628 [TBL] [Abstract][Full Text] [Related]
4. National study of discontinuation of long-term opioid therapy among veterans. Vanderlip ER; Sullivan MD; Edlund MJ; Martin BC; Fortney J; Austen M; Williams JS; Hudson T Pain; 2014 Dec; 155(12):2673-2679. PubMed ID: 25277462 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of policy and risk targeting for opioid-related risk mitigation: a randomised programme evaluation with stepped-wedge design. Minegishi T; Garrido MM; Pizer SD; Frakt AB BMJ Open; 2018 Jun; 8(6):e020097. PubMed ID: 29950460 [TBL] [Abstract][Full Text] [Related]
6. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Lovejoy TI; Morasco BJ; Demidenko MI; Meath THA; Frank JW; Dobscha SK Pain; 2017 Mar; 158(3):526-534. PubMed ID: 28192376 [TBL] [Abstract][Full Text] [Related]
7. Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study. Hayes CJ; Krebs EE; Brown J; Li C; Hudson T; Martin BC J Pain; 2021 Dec; 22(12):1709-1721. PubMed ID: 34186177 [TBL] [Abstract][Full Text] [Related]
8. Stimulant use and opioid-related harm in patients on long-term opioids for chronic pain. Appa A; McMahan VM; Long K; Shade SB; Coffin PO Drug Alcohol Depend; 2024 Mar; 256():111065. PubMed ID: 38245963 [TBL] [Abstract][Full Text] [Related]
9. Patient and Provider Perspectives on Benefits and Harms of Continuing, Tapering, and Discontinuing Long-Term Opioid Therapy. Nevedal AL; Timko C; Lor MC; Hoggatt KJ J Gen Intern Med; 2023 Jun; 38(8):1802-1811. PubMed ID: 36376623 [TBL] [Abstract][Full Text] [Related]
10. The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality. Gaither JR; Goulet JL; Becker WC; Crystal S; Edelman EJ; Gordon K; Kerns RD; Rimland D; Skanderson M; Justice AC; Fiellin DA J Gen Intern Med; 2016 May; 31(5):492-501. PubMed ID: 26847447 [TBL] [Abstract][Full Text] [Related]
11. Changes in pain intensity after discontinuation of long-term opioid therapy for chronic noncancer pain. McPherson S; Lederhos Smith C; Dobscha SK; Morasco BJ; Demidenko MI; Meath THA; Lovejoy TI Pain; 2018 Oct; 159(10):2097-2104. PubMed ID: 29905648 [TBL] [Abstract][Full Text] [Related]
12. Mortality After Discontinuation of Primary Care-Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study. James JR; Scott JM; Klein JW; Jackson S; McKinney C; Novack M; Chew L; Merrill JO J Gen Intern Med; 2019 Dec; 34(12):2749-2755. PubMed ID: 31468341 [TBL] [Abstract][Full Text] [Related]
13. Association of a Positive Drug Screening for Cannabis With Mortality and Hospital Visits Among Veterans Affairs Enrollees Prescribed Opioids. Keyhani S; Leonard S; Byers AL; Zaman T; Krebs E; Austin PC; Moss-Vazquez T; Austin C; Sandbrink F; Bravata DM JAMA Netw Open; 2022 Dec; 5(12):e2247201. PubMed ID: 36525274 [TBL] [Abstract][Full Text] [Related]
14. Assessment of outcomes following high-dose opioid tapering in a Veterans Healthcare System. Hundley L; Spradley S; Donelenko S J Opioid Manag; 2018; 14(2):89-101. PubMed ID: 29733095 [TBL] [Abstract][Full Text] [Related]
15. Randomized program evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM): A research and clinical operations partnership to examine effectiveness. Minegishi T; Frakt AB; Garrido MM; Gellad WF; Hausmann LRM; Lewis ET; Pizer SD; Trafton JA; Oliva EM Subst Abus; 2019; 40(1):14-19. PubMed ID: 30620691 [TBL] [Abstract][Full Text] [Related]
16. Protocol for evaluating the nationwide implementation of the VA Stratification Tool for Opioid Risk Management (STORM). Chinman M; Gellad WF; McCarthy S; Gordon AJ; Rogal S; Mor MK; Hausmann LRM Implement Sci; 2019 Jan; 14(1):5. PubMed ID: 30658658 [TBL] [Abstract][Full Text] [Related]